The α/β ratio for prostate cancer: What is it, really?
- 1 July 2005
- journal article
- editorial
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 76 (1), 1-3
- https://doi.org/10.1016/j.radonc.2005.06.009
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Dose–response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trialRadiotherapy and Oncology, 2004
- A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancerRadiotherapy and Oncology, 2004
- Is α/β for prostate tumors really low?International Journal of Radiation Oncology*Biology*Physics, 2001
- Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancerRadiotherapy and Oncology, 1999
- Fractionation and protraction for radiotherapy of prostate carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapyRadiotherapy and Oncology, 1998
- Quantifying the position and steepness of radiation dose-response curvesInternational Journal of Radiation Biology, 1997
- A rationale for fractionation for slowly proliferating tumors such as prostatic adenocarcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Is the experience with CHART compatible with experimental data? A new model of repair kinetics and computer simulationsRadiotherapy and Oncology, 1992